Home > Cashflow Statement > GLAND PHARMA

GLAND PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-417 Cr₹-433 Cr₹-799 Cr₹15 Cr₹35 Cr

What is the latest Cash Flow from Financing Activities ratio of GLAND PHARMA ?

The latest Cash Flow from Financing Activities ratio of GLAND PHARMA is ₹-417 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-417 Cr
Mar2025₹-433 Cr
Mar2024₹-799 Cr
Mar2023₹15 Cr
Mar2022₹35 Cr

How is Cash Flow from Financing Activities of GLAND PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-417 Cr
Negative
Mar2025 ₹-433 Cr
Negative
Mar2024 ₹-799 Cr
Negative
Mar2023 ₹15 Cr
-57.25
Mar2022 ₹35 Cr -

Compare Cash Flow from Financing Activities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹42,907.4 Cr 0.9% 5.3% 26.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -0.1% 0.5% 14% Stock Analytics
DIVIS LABORATORIES ₹218,972.0 Cr -0.9% 21.1% 25.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,358.0 Cr -1.3% 1.1% 32.7% Stock Analytics
CIPLA ₹118,916.0 Cr 0.2% 2.1% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,824.0 Cr 0.2% -7.7% -7.5% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

0.9%

5.3%

26.7%

SENSEX

0.5%

2.6%

-3.7%


You may also like the below Video Courses